Nektar Therapeutics
Символ: 0UNL.L
LSE
1.7883
USDПазарна цена днес
-1.2376
Съотношение P/E
0.0074
Коефициент PEG
349.95M
MRK Cap
- 0.00%
Доходност на DIV
Nektar Therapeutics (0UNL-L) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1542.53 | 303.6 | 505 | 734 | ||||||||||||
balance-sheet.row.short-term-investments | 1359.96 | 283.5 | 438.1 | 719.7 | ||||||||||||
balance-sheet.row.net-receivables | 12.54 | 2.3 | 6 | 23.9 | ||||||||||||
balance-sheet.row.inventory | 72.16 | 16.1 | 19.2 | 15.8 | ||||||||||||
balance-sheet.row.other-current-assets | 34.62 | 8.7 | 15.8 | 21.9 | ||||||||||||
balance-sheet.row.total-current-assets | 1661.85 | 330.7 | 546 | 795.6 | ||||||||||||
balance-sheet.row.property-plant-equipment-net | 196.4 | 36.9 | 85.9 | 177.5 | ||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 76.5 | 76.5 | ||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 76.5 | 76.5 | ||||||||||||
balance-sheet.row.long-term-investments | 25.82 | 25.8 | 0 | 64.8 | ||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.other-non-current-assets | 12.22 | 4.6 | 2.2 | 2.7 | ||||||||||||
balance-sheet.row.total-non-current-assets | 234.45 | 67.3 | 164.6 | 321.6 | ||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-assets | 1896.3 | 398 | 710.6 | 1117.2 | ||||||||||||
balance-sheet.row.account-payables | 19.45 | 9.8 | 13 | 9.7 | ||||||||||||
balance-sheet.row.short-term-debt | 76.06 | 19.3 | 18.7 | 17.4 | ||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.long-term-debt-total | 517.02 | 112.6 | 126.5 | 148.1 | ||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||
balance-sheet.row.other-current-liab | 118.44 | 22.2 | 36.6 | 58 | ||||||||||||
balance-sheet.row.total-non-current-liabilities | 954.17 | 215.8 | 275.8 | 352.5 | ||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.capital-lease-obligations | 415.92 | 98.5 | 112.8 | 125.7 | ||||||||||||
balance-sheet.row.total-liab | 1168.12 | 267 | 344 | 437.7 | ||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.common-stock | 0.08 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.retained-earnings | -13639.96 | -3477.2 | -3201.2 | -2833 | ||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -18.4 | 0.1 | -6.9 | -4.2 | ||||||||||||
balance-sheet.row.other-total-stockholders-equity | 14386.47 | 3608.1 | 3574.7 | 3516.6 | ||||||||||||
balance-sheet.row.total-stockholders-equity | 728.18 | 131 | 366.6 | 679.5 | ||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 1896.3 | 398 | 710.6 | 1117.2 | ||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-equity | 728.18 | 131 | 366.6 | 679.5 | ||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 1896.3 | - | - | - | ||||||||||||
Total Investments | 1385.78 | 309.3 | 438.1 | 784.5 | ||||||||||||
balance-sheet.row.total-debt | 1009 | 230.4 | 258 | 291.3 | ||||||||||||
balance-sheet.row.net-debt | 826.43 | 210.2 | 191.1 | 277 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -276.06 | -276.1 | -368.2 | -523.8 | ||||||||||||
cash-flows.row.depreciation-and-amortization | 7.82 | 7.8 | 12.2 | 13 | ||||||||||||
cash-flows.row.deferred-income-tax | -0.14 | -0.1 | 2.7 | -106.6 | ||||||||||||
cash-flows.row.stock-based-compensation | 33.39 | -13 | 57.3 | 94.7 | ||||||||||||
cash-flows.row.change-in-working-capital | -19.8 | -19.8 | 0.5 | -23.1 | ||||||||||||
cash-flows.row.account-receivables | 4.78 | 4.8 | 16.5 | 12.4 | ||||||||||||
cash-flows.row.inventory | 0.7 | 0.7 | -3.4 | -0.5 | ||||||||||||
cash-flows.row.account-payables | -2.88 | -2.9 | 3.1 | -11.7 | ||||||||||||
cash-flows.row.other-working-capital | -22.39 | -22.4 | -15.7 | -23.3 | ||||||||||||
cash-flows.row.other-non-cash-items | 108.61 | 108.6 | -8.5 | 133.1 | ||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -192.61 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -0.86 | -0.9 | -5.7 | -15 | ||||||||||||
cash-flows.row.acquisitions-net | -82.74 | 1.2 | 13.2 | -217.8 | ||||||||||||
cash-flows.row.purchases-of-investments | -511.7 | -511.7 | -467.9 | -960.7 | ||||||||||||
cash-flows.row.sales-maturities-of-investments | 650.88 | 650.9 | 826.2 | 1178.5 | ||||||||||||
cash-flows.row.other-investing-activites | 140.43 | 0 | 0 | 217.8 | ||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 139.56 | 139.6 | 365.8 | 202.8 | ||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.common-stock-issued | 0.03 | 0 | 0.8 | 33.2 | ||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.other-financing-activites | 0.03 | 0 | 0.8 | 3 | ||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0.03 | 0 | 1.5 | 36.2 | ||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.06 | 6.3 | -0.3 | -0.1 | ||||||||||||
cash-flows.row.net-change-in-cash | -46.67 | -46.7 | 52.5 | -175.1 | ||||||||||||
cash-flows.row.cash-at-end-of-period | 182.57 | 20.2 | 66.8 | 14.3 | ||||||||||||
cash-flows.row.cash-at-beginning-of-period | 229.24 | 66.8 | 14.3 | 189.3 | ||||||||||||
cash-flows.row.operating-cash-flow | -192.61 | -192.6 | -304 | -412.7 | ||||||||||||
cash-flows.row.capital-expenditure | -0.86 | -0.9 | -5.7 | -15 | ||||||||||||
cash-flows.row.free-cash-flow | -193.47 | -193.5 | -309.7 | -427.6 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 90.12 | 90.1 | 92.1 | 101.9 | ||||||||||||
income-statement-row.row.cost-of-revenue | 33.77 | 36.6 | 29.1 | 34.7 | ||||||||||||
income-statement-row.row.gross-profit | 56.35 | 53.5 | 62.9 | 67.2 | ||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.research-development | 114.16 | - | - | - | ||||||||||||
income-statement-row.row.selling-general-administrative | 77.42 | - | - | - | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.operating-expenses | 191.58 | 190.9 | 303.2 | 513.3 | ||||||||||||
income-statement-row.row.cost-and-expenses | 225.35 | 227.5 | 332.3 | 548 | ||||||||||||
income-statement-row.row.interest-income | 8.59 | 19 | 22.2 | 44.7 | ||||||||||||
income-statement-row.row.interest-expense | 25.33 | 25.3 | 28.9 | 47.3 | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.total-other-income-expensenet | -141.03 | -138.8 | -124.7 | -77.2 | ||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.total-operating-expenses | -141.03 | -138.8 | -124.7 | -77.2 | ||||||||||||
income-statement-row.row.interest-expense | 25.33 | 25.3 | 28.9 | 47.3 | ||||||||||||
income-statement-row.row.depreciation-and-amortization | 7.82 | 7.8 | 12.2 | 13 | ||||||||||||
income-statement-row.row.ebitda-caps | -127.41 | - | - | - | ||||||||||||
income-statement-row.row.operating-income | -135.22 | -137.4 | -240.2 | -446.1 | ||||||||||||
income-statement-row.row.income-before-tax | -276.26 | -276.3 | -365 | -523.3 | ||||||||||||
income-statement-row.row.income-tax-expense | -0.2 | -0.2 | 3.2 | 0.6 | ||||||||||||
income-statement-row.row.net-income | -276.06 | -276.1 | -368.2 | -523.8 |
Често задавани въпроси
Какво е Nektar Therapeutics (0UNL.L) общи активи?
Nektar Therapeutics (0UNL.L) общите активи са 398033000.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 48029000.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е -1.013.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е -1.013.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е -3.063.
Какъв е общият приход на предприятието?
Общият приход е -1.500.
Каква е Nektar Therapeutics (0UNL.L) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е -276056000.000.
Какъв е общият дълг на фирмата?
Общият дълг е 230401000.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 190903000.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 20161000.000.